-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND Holds Training Session for Phase III Clinical Trial of NL002 Project
On May 29, 2015, NORTHLAND organized a training session for the Phase III clinical trial of the NL002 project. The meeting specially invited representatives from the leading clinical trial unit—the Clinical Trial Institution of Fudan University Affiliated Tumor Hospital and relevant officials from the Department of Medical Oncology—to provide training for personnel from the company’s Clinical Medicine Department, Registration Department, and General Engineering Office.
This training session focused on learning and discussing key points related to the verification of raw data from the NL002 clinical trial, evaluation criteria for safety and efficacy endpoints, and important considerations for clinical monitoring. Through this training, relevant personnel have further clarified the clinical research standards and operational procedures for oncology-related drugs, thereby ensuring the smooth implementation of the Phase III clinical study for the NL002 project.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005